NEW YORK, April 6 (GenomeWeb News) - Laboratory automation firm RoboDesign International said today that the Structural Genomics Consortium has selected its CrystalMation protein crystal imaging and analysis technology as its standard protein crystallography platform.
The SGC is a not-for-profit organization funded by the Wellcome Trust, GlaxoSmithKline, Genome Canada, the Ontario Research and Development Challenge Fund, the Ontario Innovation Trust, and the Canadian Institutes of Health Research. The initiative was launched in April 2003 with the goal of developing the infrastructure and technologies necessary to determine 200 protein structures per year. The SGC said it will target 350 medically significant proteins over the first four years.
The SGC will use the Minstrel III and RoboIncubator combinations of the CrystalMation platform in its high-throughput crystallography facility at the University of Oxford. RoboDesign said that it would deliver the systems this May.
Financial terms of the agreement were not provided.